PP
ANGO icon

PDT Partners’s AngioDynamics ANGO Stock Holding History

PDT Partners’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,292
Closed -$195K – 658
2024
Q1 		$195K Sell
33,292
-37,821
-53% -$225K 0.02% 578
2023
Q4 		$558K Buy
+71,113
New +$493K 0.06% 390
2023
Q3 		– Sell
-37,515
Closed -$391K – 581
2023
Q2 		$391K Hold
37,515
– – 0.05% 418
2023
Q1 		$388K Buy
+37,515
New +$480K 0.05% 422

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

PDT Partners's ANGO Position: Q2 2024 in Review

PDT Partners sold out of AngioDynamics (ANGO) in Q2 2024, closing a stake of 33,292 shares — an estimated $195K sold.

PDT Partners first reported a position in ANGO in Q1 2023 and held it in 4 quarters. The position peaked at $558K in Q4 2023. 139 funds tracked by Wall St. Rank hold ANGO as of Q2 2024.

  • PDT Partners reported no remaining AngioDynamics position as of Q2 2024 after selling out during the quarter.
  • PDT Partners sold 33,292 AngioDynamics shares in Q2 2024, an estimated $195K.
  • PDT Partners first reported a position in AngioDynamics in Q1 2023 and held it in 4 quarters.
  • PDT Partners's AngioDynamics position peaked at $558K in Q4 2023.
  • 139 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2024.

Based on PDT Partners's 13F filing for Q2 2024, filed 15 Aug 2024.